(Q46661409)

24 December 2017

title

Analysis of impact of age and race on biochemical control after radiotherapy in different prostate cancer settings (English)

1 reference

24 December 2017

Adaptive radiation therapy

main subject

0 references

author name string

Ashesh B Jani

series ordinal

1

1 reference

24 December 2017

John Gratzle

series ordinal

2

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

24 December 2017

published in

Urology

1 reference

24 December 2017

volume

66

1 reference

24 December 2017

issue

1

1 reference

24 December 2017

page(s)

124-129

1 reference

24 December 2017

Early prostate cancer: clinical decision-making

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

Intensity-modulated radiation therapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

Advanced age at diagnosis is an independent predictor of time to death from prostate carcinoma for patients undergoing external beam radiation therapy for clinically localized prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

Prostate adenocarcinoma in men younger than 50 years. A retrospective review of 151 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

Natural History and Prognosis of Prostate Carcinoma in Adolescents and Men under 35 Years of Age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

Does age influence the behaviour of localized prostate cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

Continued undertreatment of older men with localized prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

Population-based study of pelvic lymph node positivity in clinically localized prostate cancer: a study comparing African Americans and whites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

Screening for prostate cancer in African Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

Prostate cancer in black and white Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

Clinical characteristics of African-American men with hereditary prostate cancer: the AAHPC Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

Equivalent racial outcome after conformal radiotherapy for prostate cancer: a single departmental experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

A systematic overview of radiation therapy effects in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

Nonparametric Estimation from Incomplete Observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

Survival analysis in clinical trials: past developments and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

Prostate cancer in blacks: an update from the American College of Surgeons' patterns of care studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

Differences in socioeconomic status and survival among white and black men with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

Prostate cancer in African-American men: outcome following radiation therapy with or without adjuvant androgen ablation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.01.057

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UROLOGY.2005.01.057

1 reference

24 December 2017

PubMed ID

15992908

1 reference

24 December 2017